Need professional-grade analysis? Visit stockanalysis.com
$1.57B
24.00
3,502
N/A
Price Chart
Pharmaniaga Bhd (7081) Price Performance
Pharmaniaga Bhd (7081) trades on KLSE in MYR. The company is classified in the Healthcare sector under the Medical Distribution industry. The stock currently trades at MYR0.25, up 4.17% from the previous close.
Over the past year, 7081 has traded between a low of MYR0.24 and a high of MYR0.25. The stock has gained 2.0% over this period.
Pharmaniaga Bhd has a market capitalization of $1.57B, with a price-to-earnings ratio of 24.00.
About Pharmaniaga Bhd
Pharmaniaga Berhad, an investment holding company, operates as an integrated healthcare service provider in Malaysia, Indonesia, and internationally. The company operates through three segments: Logistics and Distribution, Manufacturing, and Indonesia. It is involved in manufacturing, distribution, trading, wholesaling, and marketing pharmaceutical and medical products; and supply, trading, and installation of medical and hospital equipment. The company also manufactures and sells generic drugs; conducts research and development of pharmaceutical products; and manufactures, distributes, trades in, and sells food supplements. In addition, it distributes and trades in diagnostic products; and develops pharmacy management system for ordering management system, point-of-sale transactions, and inventory management. The company was founded in 1994 and is based in Shah Alam, Malaysia.
Compare Pharmaniaga Bhd
Side-by-side comparison against top Healthcare peers.
Company Info
- Sector
- Healthcare
- Industry
- Medical Distribution
- Exchange
- KLSE
- Currency
- MYR
- Country
- Malaysia
Financial Metrics
- Revenue (TTM)
- $3.93B
- EBITDA
- $154.29M
- Profit Margin
- 1.24%
- EPS (TTM)
- 0.01
- Book Value
- 0.07
Technical Indicators
- 52 Week High
- MYR 0.26
- 52 Week Low
- MYR 0.24
- 50 Day MA
- MYR 0.26
- 200 Day MA
- MYR 0.25
- Beta
- 0.86
Valuation
- Trailing P/E
- 24.00
- Forward P/E
- 12.00
- Price/Sales
- 0.40
- Price/Book
- 3.62
- Enterprise Value
- $2.15B